Patent ID: 8084503
Filing Date: 2011-12-27
Classification: A61P,C07C,C07D,Y10S

Abstract:
1. A method of causing regression in an inflammatory condition or disease in a mammal, wherein the disease or condition is selected from atopic dermatitis, peritonitis, asthma and rheumatoid arthritis and wherein the method comprises administering to the mammal in need thereof a therapeutically effective amount of a compound of formula (Ia): wherein: the A, C or D ring is independently fully saturated; C1, C4, C11, C12, C15 and C16 are each independently substituted with two hydrogens; C9 and C14 are each independently substituted with hydrogen; R R R R R R each R each R each R each R as a single stereoisomer, a mixture of stereoisomers, or as a racemic mixture of stereoisomers; or a pharmaceutically acceptable salt.